The use of NGS on DNA🧬 from tissue or liquid biopsies is now well established in the management of patients with cancer. In this Letter to the Editor, Arnaud Bayle and coll. present the data from cases tested with both modalities in PRISM 🇫🇷 annalsofoncology.org/article/S0923-…

The oncotype is just one factor in clinical decision making. Thanks for perspectives for this editorial Stacey Tinianov (she/her) MPH, BCPA and Ishka Que - my ASCO virtual mentee turned friend!

Another day, another drug induced liver injury patient from supplement use. Please don’t do this to your liver! It deserves better. Stop with the supplements already!!! #MedTwitter #bcsm #onctwitter #hepatology

Mismatch Repair and Microsatellite Instability Testing for ICI Therapy: ASCO Endorsement of College of American Pathologists Guideline medpagetoday.com/reading-room/a…

Well, my virtual mentorship spanned countries/oceans and time zones (as well as mixups due to daylight savings times) 😅 But definitely would agree that this is a truly valuable experience, and will always be grateful for matching with Tarah Ballinger, MD ☺️ connection.asco.org/blogs/value-vi…

🧬🦀 Fresh off the press: 11.2% of 446 pts in the 🇵🇭 had potentially pathogenic germline variants (PPGV) in NGS. High penetrance variants most common (BRCA1/2, MSH2, MSH6, MLH1, RAD51C, RAD51D). Complements guideline-based germline testing ascopubs.org/doi/10.1200/GO… JCO Global Oncology

This article was all made possible through my research mentor Ishka Que and coauthors Dr Andal and Dr Ang. Cancer genetics is not a thing of the future even in LMICs like 🇵🇭. We need to publish our own data and harness it to influence policy doi.org/10.1200/GO.24.…

Finally, our paper is out! Whole body MRI is an effective screening tool in patients with specific cancer predisposition syndromes, leading to early cancer detection and treatment. ascopubs.org/doi/10.1200/PO… #JCOPO JCO Precision Oncology